Jubilant Pharmova shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters47.68%no change
Foreign investors (FII)15.38%−0.49 pts
Domestic institutions (DII)13.02%+0.62 pts
of which mutual funds9.42%+0.43 pts
of which insurance companies1.07%
Public23.38%
Others0.54%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JUBLPHARMA₹946.00

Jubilant Pharmova Ltd.

· Pharma & Health
₹ CrorePeersGLANDPPLPHARMAKIMSINDGNONESOURCEGRANULESPFIZERPOLYMEDMcap ₹14,947 Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group50.6850.6850.6850.6847.6847.6847.6847.6847.6847.68
FII / FPI19.4917.9416.9617.2217.4016.5715.9615.9015.8715.38
DII4.075.666.987.059.5310.5211.2211.6212.4013.02
Mutual Funds2.253.063.643.666.017.137.698.038.999.42
Latest: 2026-09-30 · 61 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.